ANA MARÍA
IGLESIAS PÉREZ
Hospital de Jerez
Jerez, EspañaPublications in collaboration with researchers from Hospital de Jerez (1)
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433